How should pulmonary nodules be optimally investigated and managed?

Lung Cancer

Volumn 91, Issue , 2016, Pages 48-55

  Callister, Matthew E J ^a   Baldwin, David R ^b  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Lung cancer; Pulmonary metastasis; Pulmonary nodule

Indexed keywords

BIOLOGICAL MARKER;

COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LUNG BIOPSY; LUNG NODULE; PATIENT INFORMATION; PATIENT PREFERENCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; DISEASE MANAGEMENT; LUNG NEOPLASMS; MULTIPLE PULMONARY NODULES;

DISEASE MANAGEMENT; HUMANS; LUNG NEOPLASMS; MULTIPLE PULMONARY NODULES;

EID: 84955068258     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2015.10.018     Document Type: Review

References (113)

1. Callister M.E., Baldwin D.R., Akram A.R., et al. British thoracic society guidelines for the investigation and management of pulmonary nodules. Thorax 2015, 70(Suppl 2):ii1-ii54.
2. Naidich D.P., Bankier A.A., MacMahon H., et al. Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society. Radiology 2013, 266:304-317.
3. Gould M.K., Donington J., Lynch W.R., et al. Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013, 143:e93S-120S.
4. MacMahon H., Austin J.H.M., Gamsu G., et al. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology 2005, 237(2):395-400.
5. Quint L.E., Park C.H., Iannettoni M.D. Solitary pulmonary nodules in patients with extrapulmonary neoplasms. Radiology 2000, 217:257-261.
6. Khokhar S., Vickers A., Moore M.S., et al. Significance of non-calcified pulmonary nodules in patients with extrapulmonary cancers. Thorax 2006, 61:331-336.
7. Swensen S.J., Silverstein M.D., Ilstrup D.M., et al. The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules. Arch. Intern. Med. 1997, 157:849-855.
8. Yuan Y., Matsumoto T., Hiyama A., et al. The probability of malignancy in small pulmonary nodules coexisting with potentially operable lung cancer detected by CT. Eur. Radiol. 2003, 13:2447-2453.
9. Kim Y.H., Lee K.S., Primack S.L., et al. Small pulmonary nodules on CT accompanying surgically resectable lung cancer: likelihood of malignancy. J. Thorac. Imaging 2002, 17:40-46.
10. Keogan M.T., Tung K.T., Kaplan D.K., et al. The significance of pulmonary nodules detected on CT staging for lung cancer. Clin. Radiol. 1993, 48:94-96.
11. Gould M.K., Ananth L., Barnett P.G., et al. A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules. Chest 2007, 131:383-388.
12. Li Y., Chen K.-Z., Wang J. Development and validation of a clinical prediction model to estimate the probability of malignancy in solitary pulmonary nodules in Chinese people. Clin. Lung Cancer 2011, 12:313-319.
13. Yonemori K., Tateishi U., Uno H., et al. Development and validation of diagnostic prediction model for solitary pulmonary nodules. Respirology 2007, 12:856-862.
14. Herder G.J., van Tinteren H., Golding R.P., et al. Clinical prediction model to characterize pulmonary nodules: validation and added value of 18F-fluorodeoxyglucose positron emission tomography. Chest 2005, 128:2490-2496.
15. McWilliams A., Tammemagi M.C., Mayo J.R., et al. Probability of cancer in pulmonary nodules detected on first screening CT. N. Engl. J. Med. 2013, 369:910-919.
16. Al-Ameri A., Malhotra P., Thygesen H., et al. Risk of malignancy in pulmonary nodules: a validation study of four prediction models. Lung Cancer 2015, 89:27-30.
17. de Hoop B., van Ginneken B., Gietema H., et al. Pulmonary perifissural nodules on CT scans: rapid growth is not a predictor of malignancy. Radiology 2012, 265:611-616.
18. Ahn M.I., Gleeson T.G., Chan I.H., et al. Perifissural nodules seen at CT screening for lung cancer. Radiology 2010, 254:949-956.
19. National Lung Screening Trial Research Team, Church T.R., Black W.C., et al. Results of initial low-dose computed tomographic screening for lung cancer. N. Engl. J. Med. 2013, 368:1980-1991.
20. Aberle D.R., DeMello S., Berg C.D., et al. Results of the two incidence screenings in the national lung screening trial. N. Engl. J. Med. 2013, 369:920-931.
21. Horeweg N., van Rosmalen J., Heuvelmans M.A., et al. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. Lancet Oncol. 2014, 15:1332-1341.
22. lvan Klavere R.J., Oudkerk M., Prokop M., et al. Management of lung nodules detected by volume CT scanning. N. Engl. J. Med. 2009, 2221-2229.
23. Chu X.-Y., Hou X.-B., Song W.-A., et al. Diagnostic values of SCC, CEA, Cyfra21-1 and NSE for lung cancer in patients with suspicious pulmonary masses: a single center analysis. Cancer Biol. Ther. 2011, 11:995-1000.
24. Shen J., Liu Z., Todd N.W., et al. Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers. BMC Cancer 2011, 11:374.
25. Daly S., Rinewalt D., Fhied C., et al. Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodules. J. Thorac. Oncol. 2013, 8:31-36.
26. Higgins G., Roper K.M., Watson I.J., et al. Variant Ciz1 is a circulating biomarker for early-stage lung cancer. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:E3128-E3135.
27. Boyle P., Chapman C.J., Holdenrieder S., et al. Clinical validation of an autoantibody test for lung cancer. Ann. Oncol. 2011, 22:383-389.
28. Lam S., Boyle P., Healey G.F., et al. EarlyCDT-Lung: an immunobiomarker test as an aid to early detection of lung cancer. Cancer Prev. Res. (Phila) 2011, 4:1126-1134.
29. Jett J.R., Peek L.J., Fredericks L., et al. Audit of the autoantibody test, EarlyCDT(R)-lung, in 1600 patients: an evaluation of its performance in routine clinical practice. Lung Cancer 2014, 83:51-55.
30. Gould M.K., Maclean C.C., Kuschner W.G., et al. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis (structured abstract). JAMA 2001, 914-924.
31. Cronin P., Dwamena B.A., Kelly A.M., et al. Solitary pulmonary nodules: meta-analytic comparison of cross-sectional imaging modalities for diagnosis of malignancy. Radiology 2008, 246:772-782.
32. Nie Y., Li Q., Li F., et al. Integrating PET and CT information to improve diagnostic accuracy for lung nodules: a semiautomatic computer-aided method. J. Nucl. Med. 2006, 47:1075-1080.
33. Veronesi G., Bellomi M., Veronesi U., et al. Role of positron emission tomography scanning in the management of lung nodules detected at baseline computed tomography screening. Ann. Thorac. Surg. 2007, 84(3):959-966.
34. Ashraf H., Dirksen A., Loft A., et al. Combined use of positron emission tomography and volume doubling time in lung cancer screening with low-dose CT scanning. Thorax 2011, 315-319.
35. Pastorino U., Bellomi M., Landoni C., et al. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results. Lancet 2003, 593-597.
36. Kinahan P.E., Fletcher J.W. Positron emission tomography-computed tomography standardized uptake values in clinical practice and assessing response to therapy. Semin Ultrasound CT MR 2010, 31:496-505.
37. Vansteenkiste J.F., Stroobants S.G., Dupont P.J., et al. FDG-PET scan in potentially operable non-small cell lung cancer: do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases? The Leuven Lung Cancer Group. Eur. J. Nucl. Med. 1998, 25:1495-1501.
38. Fletcher J.W., Kymes S.M., Gould M., et al. A comparison of the diagnostic accuracy of 18F-FDG PET and CT in the characterization of solitary pulmonary nodules. J. Nucl. Med. 2008, 49:179-185.
39. Wu L.M., Xu J.R., Hua J., et al. Can diffusion-weighted imaging be used as a reliable sequence in the detection of malignant pulmonary nodules and masses?. Magn. Reson. Imaging 2013, 31:235-246.
40. Mamata H., Tokuda J., Gill R.R., et al. Clinical application of pharmacokinetic analysis as a biomarker of solitary pulmonary nodules: dynamic contrast-enhanced MR imaging. Magn. Reson. Med. 2012, 68:1614-1622.
41. Ohno Y., Koyama H., Matsumoto K., et al. Differentiation of malignant and benign pulmonary nodules with quantitative first-pass 320-detector row perfusion CT versus FDG PET/CT. Radiology 2011, 258:599-609.
42. van ', t W., esteinde S.C., Horeweg N., Vernhout R.M., et al. The role of conventional bronchoscopy in the workup of suspicious CT scan screen-detected pulmonary nodules. Chest 2012, 142:377-384.
43. Baaklini W.A., Reinoso M.A., Gorin A.B., et al. Diagnostic yield of fiberoptic bronchoscopy in evaluating solitary pulmonary nodules. Chest 2000, 117:1049-1054.
44. Aoshima M., Chonabayashi N. Can HRCT: contribute in decision-making on indication for flexible bronchoscopy for solitary pulmonary nodules and masses?. J. Bronchol. 2001, 8(3):161-165.
45. Herth F.J.F., Eberhardt R., Becker H.D., et al. Endobronchial ultrasound-guided transbronchial lung biopsy in fluoroscopically invisible solitary pulmonary nodules: a prospective trial. Chest 2006, 129:147-150.
46. Eberhardt R., Ernst A., Herth F.J.F. Ultrasound-guided transbronchial biopsy of solitary pulmonary nodules less than 20mm. Eur. Respir. J. 2009, 34:1284-1287.
47. Kurimoto N., Miyazawa T., Okimasa S., et al. Endobronchial ultrasonography using a guide sheath increases the ability to diagnose peripheral pulmonary lesions endoscopically. Chest 2004, 126:959-965.
48. Eberhardt R., Morgan R.K., Ernst A., et al. Comparison of suction catheter versus forceps biopsy for sampling of solitary pulmonary nodules guided by electromagnetic navigational bronchoscopy. Respiration 2010, 79:54-60.
49. Gildea T.R., Mazzone P.J., Karnak D., et al. Electromagnetic navigation diagnostic bronchoscopy: a prospective study. Am. J. Respir. Crit. Care Med. 2006, 174:982-989.
50. Jensen K.W., Hsia D.W., Seijo L.M., et al. Multicenter experience with electromagnetic navigation bronchoscopy for the diagnosis of pulmonary nodules. J. Bronchol. Interv. Pulmonol. 2012, 19(3):195-199.
51. Seijo L.M., de T., orres J.P., Lozano M.D., et al. Diagnostic yield of electromagnetic navigation bronchoscopy is highly dependent on the presence of a Bronchus sign on CT imaging: results from a prospective study. Chest 2010, 138:1316-1321.
52. Schwarz C., Schonfeld N., Bittner R.C., et al. Value of flexible bronchoscopy in the pre-operative work-up of solitary pulmonary nodules. Eur. Respir. J. 2013, 41:177-182.
53. Baldwin D.R., Eaton T., Kolbe J., et al. Management of solitary pulmonary nodules: how do thoracic computed tomography and guided fine needle biopsy influence clinical decisions?. Thorax 2002, 57:817-822.
54. Gupta S., Krishnamurthy S., Broemeling L.D., et al. Small (<=2-cm) subpleural pulmonary lesions: Short-versus long-needle-path CT-guided biopsy-comparison of diagnostic yields and complications. Radiology 2005, 234(2):631-637.
55. Hayashi N., Sakai T., Kitagawa M., et al. CT-guided biopsy of pulmonary nodules less than 3cm: usefulness of the spring-operated core biopsy needle and frozen-section pathologic diagnosis. AJR Am. J. Roentgenol. 1998, 170:329-331.
56. Jin K.N., Park C.M., Goo J.M., et al. Initial experience of percutaneous transthoracic needle biopsy of lung nodules using C-arm cone-beam CT systems. Eur. Radiol. 2010, 20:2108-2115.
57. Ohno Y., Hatabu H., Takenaka D., et al. Transthoracic CT-guided biopsy with multiplanar reconstruction image improves diagnostic accuracy of solitary pulmonary nodules. Eur. J. Radiol. 2004, 51:160-168.
58. Romano M., Griffo S., Gentile M., et al. CT guided percutaneous fine needle biopsy of small lung lesions in outpatients: safety and efficacy of the procedure compared to inpatients. Radiol. Med. 2004, 108:275-282.
59. Santambrogio L., Nosotti M., Bellaviti N., et al. CT-guided fine-needle aspiration cytology of solitary pulmonary nodules: a prospective, randomized study of immediate cytologic evaluation. Chest 1997, 423-425.
60. Tsukada H., Satou T., Iwashima A., et al. Diagnostic accuracy of CT-guided automated needle biopsy of lung nodules. Am. J. Roentgenol. 2000, 175(1):239-243.
61. Wagnetz U., Menezes R.J., Boerner S., et al. CT screening for lung cancer: implication of lung biopsy recommendations. AJR Am. J. Roentgenol. 2012, 198:351-358.
62. Westcott J.L., Rao N., Colley D.P. Transthoracic needle biopsy of small pulmonary nodules. Radiology 1997, 202(1):97-103.
63. Kothary N., Lock L., Sze D.Y., et al. Computed tomography-guided percutaneous needle biopsy of pulmonary nodules: impact of nodule size on diagnostic accuracy. Clin. Lung Cancer 2009, 10:360-363.
64. Wallace M.J., Krishnamurthy S., Broemeling L.D., et al. CT-guided percutaneous fine-needle aspiration biopsy of small (< or =1-cm) pulmonary lesions. Radiology 2002, 225:823-828.
65. Ohno Y., Hatabu H., Takenaka D., et al. CT-guided transthoracic needle aspiration biopsy of small (< or =20mm) solitary pulmonary nodules. AJR Am. J. Roentgenol. 2003, 180:1665-1669.
66. Choi S.H., Chae E.J., Kim J.E., et al. Percutaneous CT-guided aspiration and core biopsy of pulmonary nodules smaller than 1cm: analysis of outcomes of 305 procedures from a tertiary referral center. AJR Am. J. Roentgenol. 2013, 201:964-970.
67. De Filippo M., Saba L., Concari G., et al. Predictive factors of diagnostic accuracy of CT-guided transthoracic fine-needle aspiration for solid noncalcified, subsolid and mixed pulmonary nodules. Radiol. Med. 2013, 118:1071-1081.
68. Wiener R.S., Schwartz L.M., Woloshin S., et al. Population-based risk for complications after transthoracic needle lung biopsy of a pulmonary nodule: an analysis of discharge records. Ann. Intern. Med. 2011, 155:137-144.
69. Louie A.V., Rodrigues G., Hannouf M., et al. Stereotactic body radiotherapy versus surgery for medically operable Stage I non-small-cell lung cancer: a Markov model-based decision analysis. Int. J. Radiat. Oncol. Biol. Phys. 2011, 81:964-973.
70. Ko J.P., Berman E.J., Kaur M., et al. Pulmonary Nodules: growth rate assessment in patients by using serial CT and three-dimensional volumetry. Radiology 2012, 262:662-671.
71. Revel M.-P., Merlin A., Peyrard S., et al. Software volumetric evaluation of doubling times for differentiating benign versus malignant pulmonary nodules. AJR Am. J. Roentgenol. 2006, 187:135-142.
72. Henschke C.I., Yankelevitz D.F., Yip R., et al. Lung cancers diagnosed at annual CT screening: volume doubling times. Radiology 2012, 263:578-583.
73. Hasegawa M., Sone S., Takashima S., et al. Growth rate of small lung cancers detected on mass CT screening. Br. J. Radiol. 2000, 73:1252-1259.
74. Winer-Muram H.T., Jennings S.G., Tarver R.D., et al. Volumetric growth rate of stage I lung cancer prior to treatment: serial CT scanning. Radiology 2002, 223:798-805.
75. Jennings S.G., Winer-Muram H.T., Tann M., et al. Distribution of stage I lung cancer growth rates determined with serial volumetric CT measurements. Radiology 2006, 241:554-563.
76. Wilson D.O., Ryan A., Fuhrman C., et al. Doubling times and CT screen-detected lung cancers in the Pittsburgh lung screening study. Am. J. Respir. Crit. Care Med. 2012, 185:85-89.
77. Heo E.Y., Lee K.W., Jheon S., et al. Surgical resection of highly suspicious pulmonary nodules without a tissue diagnosis. Jpn. J. Clin. Oncology 2011, 41:1017-1022.
78. Sihoe A.D., Hiranandani R., Wong H., et al. Operating on a suspicious lung mass without a preoperative tissue diagnosis: pros and cons. Eur J. Cardiothorac. Surg. 2013, 44:231-237. discussion 237.
79. Cardillo G., Regal M., Sera F., et al. Videothoracoscopic management of the solitary pulmonary nodule: a single-institution study on 429 cases. Ann. Thorac. Surg. 2003, 75:1607-1611. discussion 1611-2.
80. Murasugi M., Onuki T., Ikeda T., et al. The role of video-assisted thoracoscopic surgery in the diagnosis of the small peripheral pulmonary nodule. Surg. Endosc. 2001, 15:734-736.
81. Mack M.J., Hazelrigg S.R., Landreneau R.J., et al. Thoracoscopy for the diagnosis of the indeterminate solitary pulmonary nodule. Ann. Thorac. Surg. 1993, 56:825-830. discussion 830-832discussion/EndRef>.
82. Jimenez M.F. Spanish video-assisted thoracic surgery study GL: prospective study on video-assisted thoracoscopic surgery in the resection of pulmonary nodules: 209 cases from the Spanish video-assisted thoracic surgery study group. Eur. J. Cardiothorac. Surg. 2001, 19:562-565.
83. Varoli F., Vergani C., Caminiti R., et al. Management of solitary pulmonary nodule. Eur. J. Cardiothorac. Surg. 2008, 33:461-465.
84. Paul S., Isaacs A.J., Treasure T., et al. Long term survival with thoracoscopic versus open lobectomy: propensity matched comparative analysis using SEER-medicare database. BMJ 2014, 349:g5575.
85. Billmeier S.E., Ayanian J.Z., Zaslavsky A.M., et al. Predictors and outcomes of limited resection for early-stage non-small cell lung cancer. J. Natl. Cancer Inst. 2011, 103:1621-1629.
86. Okami J., Ito Y., Higashiyama M., et al. Sublobar resection provides an equivalent survival after lobectomy in elderly patients with early lung cancer. Ann. Thorac. Surg. 2010, 90:1651-1656.
87. Miller D.L., Rowland C.M., Deschamps C., et al. Surgical treatment of non-small cell lung cancer 1cm or less in diameter. Ann. Thorac. Surg. 2002, 73:1545-1550. discussion 1550-1.
88. Sienel W., Dango S., Kirschbaum A., et al. Sublobar resections in stage IA non-small cell lung cancer: segmentectomies result in significantly better cancer-related survival than wedge resections. Eur. J. Cardiothorac. Surg. 2008, 33:728-734.
89. Schuchert M.J., Abbas G., Awais O., et al. Anatomic segmentectomy for the solitary pulmonary nodule and early-stage lung cancer. Ann. Thorac. Surg. 2012, 93(6):1780-1787.
90. Landreneau R.J., Normolle D.P., Christie N.A., et al. Recurrence and survival outcomes after anatomic segmentectomy versus lobectomy for clinical stage I non-small-cell lung cancer: a propensity-matched analysis. J. Clin. Oncol. 2014, 32:2449-2455.
91. Tsutani Y., Miyata Y., Nakayama H., et al. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study. J. Thorac. Cardiovasc. Surg. 2013, 146:358-364.
92. Bao F., Ye P., Yang Y., et al. Segmentectomy or lobectomy for early stage lung cancer: a meta-analysis. Eur. J. Cardiothorac. Surg. 2014, 46:1-7.
93. Takeda A., Kunieda E., Sanuki N., et al. Stereotactic body radiotherapy (SBRT) for solitary pulmonary nodules clinically diagnosed as lung cancer with no pathological confirmation: comparison with non-small-cell lung cancer. Lung Cancer 2012, 77(1):77-82.
94. Stephans K.L., Djemil T., Reddy C.A., et al. A comparison of two stereotactic body radiation fractionation schedules for medically inoperable stage I non-small cell lung cancer: the Cleveland clinic experience. J. Thorac. Oncol. 2009, 4:976-982.
95. Haidar Y.M., Rahn D.A., Nath S., et al. Comparison of outcomes following stereotactic body radiotherapy for non-small cell lung cancer in patients with and without pathological confirmation. Ther. Adv. Respir. Dis. 2014, 8:3-12.
96. Verstegen N.E., Lagerwaard F.J., Haasbeek C.J., et al. Outcomes of stereotactic ablative radiotherapy following a clinical diagnosis of stage I NSCLC: comparison with a contemporaneous cohort with pathologically proven disease. Radiother. Oncol. 2011, 101:250-254.
97. Verstegen N.E., Oosterhuis J.W., Palma D.A., et al. Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis. Ann. Oncol. 2013, 24:1543-1548.
98. Crabtree T.D., Denlinger C.E., Meyers B.F., et al. Stereotactic body radiation therapy versus surgical resection for stage I non-small cell lung cancer. J. Thorac. Cardiovasc. Surg. 2010, 140:377-386.
99. Chang J.Y., Senan S., Paul M.A., et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Oncol. 2015, 16:630-637.
100. Matsuguma H., Mori K., Nakahara R., et al. Characteristics of subsolid pulmonary nodules showing growth during follow-up with CT scanning. Chest 2013, 143:436-443.
101. Ichinose J., Kohno T., Fujimori S., et al. Invasiveness and malignant potential of pulmonary lesions presenting as pure ground-glass opacities. Ann. Thorac. Cardiovasc. Surg. 2014, 20:347-352.
102. Takahashi S., Tanaka N., Okimoto T., et al. Long term follow-up for small pure ground-glass nodules: implications of determining an optimum follow-up period and high-resolution CT findings to predict the growth of nodules. Jpn. J. Radiol. 2012, 30:206-217.
103. Fan L., Liu S.Y., Li Q.C., et al. Multidetector CT features of pulmonary focal ground-glass opacity: differences between benign and malignant. Br. J. Radiol. 2012, 85:897-904.
104. Lee S.M., Park C.M., Goo J.M., et al. Transient part-solid nodules detected at screening thin-section CT for lung cancer: comparison with persistent part-solid nodules. Radiology 2010, 255:242-251.
105. Zhao Y.R., Heuvelmans M.A., Dorrius M.D., et al. Features of resolving and nonresolving indeterminate pulmonary nodules at follow-up CT: the NELSON study. Radiology 2014, 270:872-879.
106. Iwata H., Shirahashi K., Mizuno Y., et al. Feasibility of segmental resection in non-small-cell lung cancer with ground-glass opacity. Eur. J. Cardiothorac. Surg. 2014, 46:375-379. discussion 379.
107. Tsutani Y., Miyata Y., Yamanaka T., et al. Solid tumors versus mixed tumors with a ground-glass opacity component in patients with clinical stage IA lung adenocarcinoma: prognostic comparison using high-resolution computed tomography findings. J. Thorac. Cardiovasc. Surg. 2013, 146:17-23.
108. Gulati C.M., Schreiner A.M., Libby D.M., et al. Outcomes of unresected ground-glass nodules with cytology suspicious for adenocarcinoma. J. Thorac. Oncol. 2014, 9:685-691.
109. Maeyashiki T., Suzuki K., Hattori A., et al. The size of consolidation on thin-section computed tomography is a better predictor of survival than the maximum tumour dimension in resectable lung cancer. Eur. J. Cardiothorac. Surg. 2013, 43:915-918.
110. Lemonnier I., Baumann C., Jolly D., et al. Solitary pulmonary nodules: consequences for patient quality of life. Qual. Life Res. 2011, 20:101-109.
111. van den Bergh K.A., Essink-Bot M.L., Borsboom G.J., et al. Short-term health-related quality of life consequences in a lung cancer CT screening trial (NELSON). Br. J. Cancer 2010, 102:27-34.
112. Wiener R.S., Gould M.K., Woloshin S., et al. What do you mean, a spot?: A qualitative analysis of patients' reactions to discussions with their physicians about pulmonary nodules. Chest 2013, 143:672-677.
113. Ginsberg R.J., Rubinstein L.V. Randomised trial of lobectomy versus limited resection for T1 N0 Non-Small Cell Lung Cancer. Ann. Thorac. Surg. 1995, 60:615-623.